发明名称 Heterocyclic compound and use thereof
摘要 Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease, attention deficit hyperactivity disorder (ADHD) and the like. The compound represented by formula (I):; wherein each symbol is as defined in the DESCRIPTION, or a salt thereof has an AMPA receptor function enhancing action, and is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like.
申请公布号 US9493484(B2) 申请公布日期 2016.11.15
申请号 US201314377106 申请日期 2013.02.07
申请人 Takeda Pharmaceutical Company Limited 发明人 Toyofuku Masashi;Nakamura Shinji;Honda Eiji
分类号 C07D513/04;C07D513/08;C07D513/18 主分类号 C07D513/04
代理机构 Hamre, Schumann, Mueller & Larson, P.C. 代理人 Hamre, Schumann, Mueller & Larson, P.C.
主权项 1. A compound represented by the formula (I)wherein R1 is(1) C1-6 alkyl optionally substituted by 1 to 3 substituents selected from a halogen atom and C1-6 alkoxy;(2) C3-7 cycloalkyl;(3) phenyl optionally substituted by 1 to 3 substituents selected from a halogen atom, cyano, C1-6 alkyl optionally substituted by 1 to 3 halogen atoms and C1-6 alkoxy;(4) dihydrobenzofuranyl;(5) benzodioxolyl substituted by 1 to 3 halogen atoms;(6) pyridyl optionally substituted by 1 to 3 substituents selected from a halogen atom and C1-6 alkyl optionally substituted by 1 to 3 halogen atoms;(7) pyrimidinyl;(8) isoxazolyl substituted by 1 to 3 C1-6 alkyls;(9) tetrahydrofuranyl; or(10) pyrazolyl; L1 is a bond, —O— or CH2—O—; ring D is a benzene ring; a partial structure:wherein L2A is a bond or —O—CH2—; or L2B is a bond,or a salt thereof.
地址 Osaka JP